Liver and renal function tests remained within normal limits, as well as tumor markers, including alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA). Here, CEACAM5 is linked to neoplasm.